Workshop Examines Effects of Waiver Authority on Development of ACOs

J. Peter Rich J. Peter Rich is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Los Angeles office.   He co-chairs the Firm’s Insurance / Payors Affinity Group. The FTC, CMS and OIG hosted a public workshop on October 5, 2010, featuring panel and listening discussions on […]

Accountable Care Organizations Versus Medical Homes: What’s the Difference?

Kevin Fickenscher, M.D. A brief overview of one of the most discussed questions in healthcare today. In the great healthcare alphabet soup, it’s easy to lose sight of the differences between proposed solutions for making healthcare more efficient and effective.  Rather than tackling payment reform in isolation of care delivery, Accountable Care Organizations (ACOs) and […]

Inaugural National Accountable Care Organization Congress

The inaugural meeting of the National Accountable Care Congress ‘ACO Congress‘ to meet in Century City, California, October 25 – 27th, 2010. The ACO Congress represents itself as ‘the leading forum on Accountable Care Organizations (ACOs) and related delivery system and payment reform’, and will feature over 50 sessions, and a faculty of over 100 […]

Healthblawg on ACO’s: The Regulators & Lawyers Listen at HHS

Don Berwick kicked off the day-long Accountable Care Organization (ACO) Workshop and Listening Session, co-hosted by the FTC, CMS and the OIG, with a short, stirring speech that touched on his Triple Aim for health care: better care for individuals, better health for populations and reduced per-capita costs.  He committed the government to interpreting applicable statutes “wisely, […]

A ‘pulse check’ on the race!

With the March 2010 passage of the ‘Patient Protection and Affordable Care Act (PPACA), the ‘follow the money’ floodgates are once again opening for hospitals, physicians, integrated delivery systems, health plans, and consultants. This time, instead of migrating ‘HMO lite’ (neither staff nor group model) platforms into mainstream medicine via IPAs, or MeSH model JV’s, […]